Literature DB >> 9089913

Nuclear envelope protein autoantibodies in primary biliary cirrhosis.

J C Courvalin1, H J Worman.   

Abstract

A subset of patients with primary biliary cirrhosis (PBC) have autoantibodies directed against nuclear envelope proteins. The major autoantigen is gp210, a 210 kilodalton (kD) transmembrane protein of the nuclear pore complex, that is recognized by antibodies in approximately 25% of patients. The predominant epitope in gp210 that is recognized by most of the autoantibodies is a 15 amino acid stretch in the cytoplasmic, carboxyl-terminal domain of the protein. Gp210 autoantibodies are specific for PBC, as are the less frequent autoantibodies directed against LBR, a transmembrane protein of the inner nuclear membrane. Although autoantibodies against nuclear lamins, abundant intermediate filament proteins associated with the inner nuclear membrane, may be found in PBC, they are not specific for this disease. Nuclear envelope protein autoantibodies are also present in some patients without detectable antimitochondrial antibodies and may be of particular utility in diagnosing individuals with atypical presentations of PBC.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9089913     DOI: 10.1055/s-2007-1007185

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  25 in total

1.  Molecular biology and the diagnosis and treatment of liver diseases.

Authors:  Howard J Worman; Lin Feng; Naoto Mamiya
Journal:  World J Gastroenterol       Date:  1998-06       Impact factor: 5.742

Review 2.  Autoantibodies as prognostic markers in autoimmune liver disease.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2010-05-13       Impact factor: 3.199

3.  Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis.

Authors:  E I Rigopoulou; E T Davies; A Pares; K Zachou; C Liaskos; D-P Bogdanos; J Rodes; G N Dalekos; D Vergani
Journal:  Gut       Date:  2005-04       Impact factor: 23.059

4.  Presence of disease specific autoantibodies against liver sinusoidal cells in primary biliary cirrhosis.

Authors:  Ourania Sfakianaki; Maria Tzardi; Argyro Voumvouraki; Aikaterini Afgoustaki; Meri Koulentaki; Elias Kouroumalis
Journal:  World J Hepatol       Date:  2013-10-27

5.  Performance parameters of the conventional serological markers for autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2010-12-03       Impact factor: 3.199

Review 6.  The immunology of primary biliary cirrhosis: the end of the beginning?

Authors:  J M Palmer; J A Kirby; D E J Jones
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

7.  Autoantibodies from primary biliary cirrhosis patients with anti-p95c antibodies bind to recombinant p97/VCP and inhibit in vitro nuclear envelope assembly.

Authors:  K Miyachi; Y Hirano; T Horigome; T Mimori; H Miyakawa; Y Onozuka; M Shibata; M Hirakata; A Suwa; H Hosaka; S Matsushima; T Komatsu; H Matsushima; R W Hankins; M J Fritzler
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

Review 8.  [Primary biliary liver cirrhosis and overlap syndrome. Diagnosis and therapy].

Authors:  C P Strassburg; M P Manns
Journal:  Internist (Berl)       Date:  2004-01       Impact factor: 0.743

Review 9.  Role for mycobacterial infection in pathogenesis of primary biliary cirrhosis?

Authors:  Daniel Smyk; Eirini I Rigopoulou; Yoh Zen; Robin Daniel Abeles; Charalambos Billinis; Albert Pares; Dimitrios P Bogdanos
Journal:  World J Gastroenterol       Date:  2012-09-21       Impact factor: 5.742

Review 10.  Autoimmune liver serology: current diagnostic and clinical challenges.

Authors:  Dimitrios-P Bogdanos; Pietro Invernizzi; Ian-R Mackay; Diego Vergani
Journal:  World J Gastroenterol       Date:  2008-06-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.